Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Menzel Garry E Create: Alert

All | News | Filings
Date FiledTypeDescription
07/10/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Sold 47,702 shares @ $0.9108, valued at $43.4k
07/05/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 736,548 options to buy @ $0
Granted 1,251,966 options to buy @ $0
Granted 359,700 options to buy @ $0
Granted 3,568,026 options to buy @ $0
Granted 57,846 options to buy @ $0
Granted 2,715,816 options to buy @ $0
Granted 2,158,776 options to buy @ $0
07/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/15/2023 4 Menzel Garry E (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 19,441 options to buy @ $12.46, valued at $242.2k
06/01/2023 4 Menzel Garry E (Director) has filed a Form 4 on Adaptimmune Therapeutics PLC
Txns: Granted 200,646 shares @ $0
Granted 200,647 shares @ $0
Granted 209,931 shares @ $0
06/01/2023 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Disposed/sold 132,729 shares @ $0
Disposed/sold 132,730 shares @ $0
Disposed/sold 138,871 shares @ $0
Disposed/sold 138,031 options to buy @ $0.74, valued at $102.1k
Disposed/sold 433,037 options to buy @ $5.88, valued at $2.5M
Disposed/sold 305,800 options to buy @ $5.21, valued at $1.6M
Disposed/sold 238,008 options to buy @ $0.97, valued at $230.9k
Disposed/sold 3,241 restricted stock units @ $0
Disposed/sold 15,120 restricted stock units @ $0
Disposed/sold 23,165 restricted stock units @ $0
Disposed/sold 39,681 restricted stock units @ $0
05/17/2023 4 Menzel Garry E (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Granted 16,500 options to buy @ $1.82, valued at $30k
12/19/2022 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 238,008 options to buy @ $0.97, valued at $230.9k
Granted 39,681 options to buy @ $0
12/13/2022 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 10,325 shares @ $1.131, valued at $11.7k
Sold 10,613 shares @ $1.1, valued at $11.7k
Sold 11,000 shares @ $1.062, valued at $11.7k
12/09/2022 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 9,111 shares @ $1.282, valued at $11.7k
Sold 9,314 shares @ $1.254, valued at $11.7k
12/07/2022 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 8,530 shares @ $1.372, valued at $11.7k
Sold 14,886 shares @ $1.349, valued at $20.1k
12/05/2022 4 Menzel Garry E (President & CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Sold 8,408 shares @ $1.39, valued at $11.7k
Exercised 158,795 restricted stock units @ $0
Exercised 40,881 restricted stock units @ $0
Exercised 21,382 restricted stock units @ $0
11/18/2022 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Disposed/sold 6,240 options to buy @ $16.11, valued at $100.5k
Granted 2,080 options to buy @ $0
Disposed/sold 479,866 options to buy @ $16.11, valued at $7.7M
Granted 159,956 options to buy @ $0
Disposed/sold 3,500 options to buy @ $16.1, valued at $56.4k
Granted 1,167 options to buy @ $0
Disposed/sold 164,500 options to buy @ $16.1, valued at $2.6M
Granted 54,834 options to buy @ $0
Disposed/sold 4,512 options to buy @ $31.83, valued at $143.6k
Granted 821 options to buy @ $0
Disposed/sold 240,488 options to buy @ $31.83, valued at $7.7M
08/26/2022 4 Menzel Garry E (President & CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Gifted 84,527 shares @ $0
Gifted 48,202 shares @ $0
Gifted 48,202 shares @ $0
Gifted 132,730 shares @ $0
Gifted 132,730 shares @ $0
06/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/08/2022 4 Menzel Garry E (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 21,000 options to buy @ $12.96, valued at $272.2k
03/18/2022 4 Menzel Garry E (President & CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 1,425 shares @ $2.3, valued at $3.3k
12/10/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/25/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/08/2021 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 1,132 shares @ $10.098, valued at $11.4k
Granted 686 shares @ $16.1245, valued at $11.1k
01/27/2021 4 Menzel Garry E (Director) has filed a Form 4 on Stoke Therapeutics, Inc.
Txns: Granted 29,555 options to buy @ $28.57, valued at $844.4k
12/11/2020 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 245,000 options to buy @ $31.38, valued at $7.7M
03/27/2020 4 Menzel Garry E (President & CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 980 shares @ $12.75, valued at $12.5k
Granted 1,287 shares @ $10.1, valued at $13k
02/05/2020 4 Menzel Garry E (Director) has filed a Form 4 on Black Diamond Therapeutics, Inc.
Txns: Converted 51,825 shares @ $0
Converted 156,297 preferred shares @ $0
12/20/2019 4 Menzel Garry E (President and CEO) has filed a Form 4 on TCR2 THERAPEUTICS INC.
Txns: Granted 168,000 options to buy @ $16.1, valued at $2.7M
04/12/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/11/2013 4 Form 4 - Statement of changes in beneficial ownership of securities

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy